Literature DB >> 11581478

Parallel incidences of sudden infant death syndrome and infantile hypertrophic pyloric stenosis: a common cause?

S Persson1, A Ekbom, F Granath, A Nordenskjöld.   

Abstract

OBJECTIVE: To determine whether there was a correlation between the incidence of infantile hypertrophic pyloric stenosis (IHPS) and the incidence of sudden infant death syndrome (SIDS) during the period 1970 to 1997 and to discuss different causative factors that could be influencing the changing trend in incidence.
METHODS: We compared the incidence of IHPS in the Stockholm Health Care Region with the incidence of SIDS in Sweden each year between 1970 and 1997. First, the relation was assessed by calculation of a correlation coefficient; second, the relative linear decrease was estimated for the time period 1990 to 1997.
RESULTS: The incidence of IHPS increased steadily during the 1970s, from 0.5 per 1000 live births in 1970 to 2.7 in 1979. During the 1980s, the average incidence was 2.8. During the 1990s, there was a significant decrease in the number of IHPS cases in Stockholm. The incidence rate of IHPS parallels the incidence of SIDS during the study period (r = 0.58). The incidence of SIDS dropped after the risk-reduction campaign in the beginning of the 1990s, which recommended that infants sleep on their back. We could not identify any other changes of behavioral risk factors in early exposures that could explain the temporal trends.
CONCLUSIONS: The statistical findings suggest that IHPS and SIDS have causative factors in common. We suggest that prone sleeping is one of those factors.

Entities:  

Mesh:

Year:  2001        PMID: 11581478     DOI: 10.1542/peds.108.4.e70

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

1.  Maternal smoking and risk of hypertrophic infantile pyloric stenosis: 10 year population based cohort study.

Authors:  Henrik Toft Sørensen; Bente Nørgård; Lars Pedersen; Helle Larsen; Søren Paaske Johnsen
Journal:  BMJ       Date:  2002-11-02

Review 2.  Infantile hypertrophic pyloric stenosis--genetics and syndromes.

Authors:  Babette Peeters; Marc A Benninga; Raoul C M Hennekam
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-10       Impact factor: 46.802

3.  Genome-wide high-density SNP-based linkage analysis of infantile hypertrophic pyloric stenosis identifies loci on chromosomes 11q14-q22 and Xq23.

Authors:  Kate V Everett; Barry A Chioza; Christina Georgoula; Ashley Reece; Francesca Capon; Keith A Parker; Cathy Cord-Udy; Paul McKeigue; Sally Mitton; Agostino Pierro; Prem Puri; Hannah M Mitchison; Eddie M K Chung; R Mark Gardiner
Journal:  Am J Hum Genet       Date:  2008-02-28       Impact factor: 11.025

4.  Infantile hypertrophic pyloric stenosis in twins.

Authors:  Vijay Kumar Kundal; Mufique Gajdhar; Arvind Kumar Shukla; Raksha Kundal
Journal:  BMJ Case Rep       Date:  2013-04-09

5.  Similarities and differences in the epidemiology of pyloric stenosis and SIDS.

Authors:  Sarka Lisonkova; K S Joseph
Journal:  Matern Child Health J       Date:  2014-09

6.  A novel missense mutation in the transcription factor FOXF1 cosegregating with infantile hypertrophic pyloric stenosis in the extended pedigree linked to IHPS5 on chromosome 16q24.

Authors:  Kate V Everett; Paris Ataliotis; Barry A Chioza; Charles Shaw-Smith; Eddie M K Chung
Journal:  Pediatr Res       Date:  2016-11-17       Impact factor: 3.756

Review 7.  New insights into the pathogenesis of infantile pyloric stenosis.

Authors:  Christina Panteli
Journal:  Pediatr Surg Int       Date:  2009-09-16       Impact factor: 1.827

8.  Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study.

Authors:  Marie Lund; Björn Pasternak; Rie B Davidsen; Bjarke Feenstra; Camilla Krogh; Lars J Diaz; Jan Wohlfahrt; Mads Melbye
Journal:  BMJ       Date:  2014-03-11

9.  Plasma lipids, genetic variants near APOA1, and the risk of infantile hypertrophic pyloric stenosis.

Authors:  Bjarke Feenstra; Frank Geller; Lisbeth Carstensen; Paul A Romitti; Izabella Baranowska Körberg; Bruce Bedell; Camilla Krogh; Ruzong Fan; Anna Svenningsson; Michele Caggana; Agneta Nordenskjöld; James L Mills; Jeffrey C Murray; Mads Melbye
Journal:  JAMA       Date:  2013-08-21       Impact factor: 56.272

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.